Stock futures dipped Monday morning as renewed tensions between the U.S. and China rekindled trade war concerns.
Here are some of Monday’s biggest stock movers:
Biggest stock gainers
- Moderna (NASDAQ:MRNA) +7% – Shares climbed after receiving FDA approval for its next-generation COVID-19 vaccine, mNEXSPIKE (mRNA-1283), marking its third FDA-approved product. Unlike its predecessor Spikevax, mNEXSPIKE is refrigerator-stable and showed superior immune response in a Phase 3 trial with over 11,000 participants. The vaccine is approved for adults 65+ and those aged 12–64 with CDC-defined risk factors. Moderna plans to roll out mNEXSPIKE alongside Spikevax and its RSV vaccine, mRESVIA, for the 2025–2026 respiratory season.
- Cleveland-Cliffs (NYSE:CLF) +26% – Shares surged after President Trump, during a visit to a US Steel (X) plant in Pennsylvania, announced plans to double the U.S. steel tariff to 50%, set to be effective this week. Trump said the move is aimed at protecting American steel jobs and pledged no layoffs or outsourcing, with blast furnaces expected to operate at full capacity for at least a decade. The visit was also meant to rally support for US Steel’s proposed $14B deal with Japan’s Nippon Steel. Trump emphasized the tariff would make it harder for foreign competitors to undercut U.S. producers. Other steelmakers, including Nucor (NYSE:NUE) and Steel Dynamics (NASDAQ:STLD), also jumped ~10% on the news.
More on related stocks:
- Moderna, Inc. (MRNA) Bernstein 41st Annual Strategic Decisions Conference Call Transcript
- Cleveland-Cliffs: Trying To Call The Bottom Is Not Worth It
- Moderna: After A Crash From $500 To $25, I’m Buying This “Call Option” On Pandemics And Cancer
- Moderna wins FDA nod for next-gen COVID-19 shot
- Trump says he’s doubling steel tariff to 50% during US Steel plant visit